Vitro Biopharma, Inc. — Form D

Vitro Biopharma, Inc. of GOLDEN, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-01. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Christopher FurmanDirectorDenver, CO
Caroline R MosessianDirectorDenver, CO
James R MusickDirectorDenver, CO
John R PacksDirectorDenver, CO
Christopher FurmanExecutive OfficerDenver, CO
Nathan HaasExecutive OfficerDenver, CO
Caroline R MosessianExecutive OfficerDenver, CO
James R MusickExecutive OfficerDenver, CO
Tiana R StatesExecutive OfficerDenver, CO
John PacksDirectorGolden, CO
James MusickDirectorGolden, CO
James MusickExecutive OfficerGolden, CO
Thomas OhrtExecutive OfficerGolden, CO
Chris FurmanDirectorGolden, CO
Chris FurmanExecutive OfficerGolden, CO
Caroline MosessianDirectorGolden, CO
JACK ZAMORADirectorDENVER, CO
JACK ZAMORAExecutive OfficerDENVER, CO
John EvansDirectorWest Haven, CT
John EvansExecutive OfficerWest Haven, CT
ERIK D VAN HORNDirectorGolden, CO
ERIK D VAN HORNExecutive OfficerGolden, CO
ERIK VAN HORNDirectorGOLDEN, CO

Other filings by this issuer (8)

FiledFormOfferingSold
2025-06-11D$15.0M$100K
2023-04-05D/A$2.5M$993K
2023-01-23D$405K$405K
2021-10-20D$10.0M$3.0M
2020-10-08D/A$3.5M$1.0M
2020-01-23D$1.0M$500K
2010-09-30D$30K$30K
2010-01-06D$88K$88K

More